BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 28178692)

  • 41. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
    Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
    Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients who smoke.
    Huang CS; Chen CY; Huang LK; Wang WS; Yang SH
    PLoS One; 2020; 15(6):e0233687. PubMed ID: 32502149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator.
    Patel DD; Bhatavdekar JM; Ghosh N; Vora HH; Karelia NH; Shah NG; Suthar TP; Balar DB; Trivedi CR
    Cancer; 1994 Feb; 73(3):570-4. PubMed ID: 8299078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancer.
    Perez CA; Ravindranath MH; Gupta RK; Tollenaar RA; van de Velde CJ; Wood TF; Soh D; Morton DL; Bilchik AJ
    Cancer J; 2002; 8(1):55-61. PubMed ID: 11898807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum c-erbB-2 protein is a useful marker for monitoring tumor recurrence of the breast.
    Imoto S; Wada N; Hasebe T; Ochiai A; Kitoh T
    Int J Cancer; 2007 Jan; 120(2):357-61. PubMed ID: 17044019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Value of the preoperative carcinoembryonic antigen as an independent prognostic factor in cancer of the colon and rectum].
    Young Tabusso F; Payet Meza E; Celis Zapata J; Ruiz Figueroa E; Berrospi Espinoza F
    Rev Gastroenterol Peru; 2002; 22(3):213-20. PubMed ID: 12378215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Value of carcinoembryonic antigen assay in predicting hepatic metastases, local recurrence, and survival after curative resection of colorectal cancer.
    Kanellos I; Zacharakis E; Demetriades H; Christoforidis E; Kanellos D; Pramateftakis MG; Betsis D
    Surg Today; 2006; 36(10):879-84. PubMed ID: 16998681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
    Lunde OC; Havig O
    Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy.
    Uda H; Kanda M; Tanaka C; Kobayashi D; Inaoka K; Tanaka Y; Hayashi M; Iwata N; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
    Dig Surg; 2018; 35(1):55-63. PubMed ID: 28441659
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.
    Vallam KC; Guruchannabasavaiah B; Agrawal A; Rangarajan V; Ostwal V; Engineer R; Saklani A
    Colorectal Dis; 2017 Oct; 19(10):907-911. PubMed ID: 28444968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Predictive value of serum carcinoembryonic antigen level in efficacy and prognosis for patients with rectal cancer following preoperative radiochemotherapy].
    Zhang D; Zhan T; Li M; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):519-523. PubMed ID: 28534328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation between expression of miR-155 in colon cancer and serum carcinoembryonic antigen level and its contribution to recurrence and metastasis forecast.
    Hongliang C; Shaojun H; Aihua L; Hua J
    Saudi Med J; 2014 Jun; 35(6):547-53. PubMed ID: 24888652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma.
    Nonaka M; Kataoka D; Yamamoto S; Bito A; Matsuoka J; Kawada T; Takaba T
    Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):281-4. PubMed ID: 15563262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Colon carcinoma. Preoperative CEA, tumor differentiation and prognosis].
    Mentges B
    Dtsch Med Wochenschr; 1987 Aug; 112(33):1245-9. PubMed ID: 3608853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/III colon cancer.
    Mizuno H; Miyake H; Nagai H; Yoshioka Y; Shibata K; Asai S; Takamizawa J; Yuasa N
    Langenbecks Arch Surg; 2021 Sep; 406(6):1987-1997. PubMed ID: 34148158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carcinoembryonic antigen slope analysis as an early indicator for recurrence of colorectal carcinoma.
    Kimura O; Kaibara N; Nishidoi H; Okamoto T; Takebayashi M; Kawasumi H; Koga S
    Jpn J Surg; 1986 Mar; 16(2):106-11. PubMed ID: 3723883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incorporation of serum carcinoembryonic antigen levels into the prognostic grouping system of colon cancer.
    Ozawa H; Kotake K; Hosaka M; Hirata A; Nakagawa Y; Fujita S; Sugihara K
    Int J Colorectal Dis; 2017 Jun; 32(6):821-829. PubMed ID: 28185003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer.
    Margalit O; Mamtani R; Yang YX; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
    Eur J Cancer; 2018 May; 94():1-5. PubMed ID: 29502035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
    Wichmann MW; Müller C; Lau-Werner U; Strauss T; Lang RA; Hornung HM; Stieber P; Schildberg FW
    Langenbecks Arch Surg; 2000 Jul; 385(4):271-5. PubMed ID: 10958511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma.
    Qiu MZ; Lin JZ; Wang ZQ; Wang FH; Pan ZZ; Luo HY; Li YH; Zhou ZW; He YJ; Xu RH
    Int J Biol Markers; 2009; 24(4):258-64. PubMed ID: 20082274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.